Anne M. Fagan
Physiology · 2000–2020
A researcher in the Science corpus: 14 papers; trusts 1 researcher and is trusted by 7 researchers here, as inferred from the citation graph.
Subfields
- Physiology — 102 citations into it; #423 of 2,276 by trust here, #133 by citations
Whom Anne M. Fagan trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Anne M. Fagan overall
Papers from Anne M. Fagan's perspective
Ordered by how strongly the researchers Anne M. Fagan trusts endorse each paper. Same corpus, a different order for every researcher.
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B (Annals of Neurology)
- Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. (Journal of Medicinal Chemistry)
- Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B (Journal of Cerebral Blood Flow and Metabolism)
- Searching for a baseline: Functional imaging and the resting human brain (Nature Reviews Neuroscience)
- Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. (Archives of Neurology)
- Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. (Archives of Neurology)
- [11C]PIB in a nondemented population (Neurology)
- Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. (Lancet Neurology)
- Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease (Neurology)
- Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Human apoE isoforms differentially regulate brain amyloid-β peptide clearance (2011) — 1,198 citations
- Multi-modal techniques for diagnosis and prognosis of Alzheimer’s disease (2009) — 692 citations
- APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline (2020) — 1,053 citations
- Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction (2019) — 1,438 citations
- High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis (2019) — 750 citations
- Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease (2019) — 781 citations
- ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy (2017) — 1,058 citations
- Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease (2016) — 654 citations
- Sleep quality and preclinical Alzheimer Disease (2013) — 685 citations
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease (2012) — 3,500 citations
- Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. (2007) — 947 citations
- Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans (2006) — 946 citations
- P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. (2005) — 650 citations
- Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. (2000) — 927 citations